Scuola di Specializzazione Malattie Apparato Digerente Università degli Studi di Perugia (Prof. S. Fiorucci) Seminario Multisciplinare Update su Adenocarcinoma Gastrico 19/3/24
Gastric cancer March 19,24
-
Prof. Stefano Fiorucci
Professore Associato di Gastroenterologia presso l’Università degli Studi di Perugia.Read more -
Laboratori
Università degli Studi di Perugia, Dipartimento di Medicina e Chirurgia, Laboratorio di Gastroenterologia.Read more -
Contatti
Piazza L. Severi 1 - S. Andrea delle Fratte - Perugia (Pg) +39 075 585 8120 / +39 075 585 8121Read more
News
Blog
-
06 MAR 24
- 0
-
-
01 DIC 21
- 0
Stefano Fiorucci and Eleonora Distrutti- Linking liver metabolic and vascular disease via bile acid signaling- Trends in Molecular Medicine -Cell press
Available online 20 November 2021 In Press, Corrected ProofWhat are Corrected Proof articles? Review Linking liver metabolic and vascular disease via bile acid signaling StefanoFiorucci1EleonoraDistrutti2
-
-
12 NOV 21
- 0
Just accepted for publication in FASEB J- Prof. Stefano Fiorucci and co-authors report a novel mechanism of action of statins in models of NASH
A study – just accepted for publication by FASEB J – by investigators from Universities of Perugia, Federico II, Napoli and Salerno (Italy) reports that modulation of bile acid metabolism and selective activation of FXR and GPBAR1 (TGR5) is a novel mechanism of action that support beneficial effects of statins in NASH. Fiorucci S- FASEB
-
-
03 NOV 21
- 0
Università di Perugia- CLMMC- AA-21/22 Anno V. Programma Gastroenterologia-Prof. Stefano Fiorucci
Prof. Stefano Fiorucci- Programma lezioni Gastroenterologia V anno CLMMC CLMMC -2021-22 Perugia Gastroenterologia PROGRAMMA LEZIONI V ANNO
-
-
06 MAR 24
- 0
Recently published- Bile acids and COVID19. From a gastroenterology and hepatology perspective. Biochem Pharmacology December 2023
A review article by prof. Stefano Fiorucci and its group on bile acids and COVID19. Pathogenetic and therapeutic implications. Bile acids and COVID19
-
-
19 MAR 22
- 0
Just accepted for publication- Fiorucci S., et al- Novel dual CystLTR1 antagonist/GPBAR1 agonist effectively reverses liver steatosis- Frontiers in Pharmacology 2022
Precision Biotherapeutics SrL a Spinoff of the University of Perugia reports new preclinical data on its lead compound CHIN117 on liver steatosis CysLTR1-GPBAR1 agonist
-
-
08 NOV 21
- 0
-
-
08 OTT 21
- 0
Corso di Laurea in Medicina e Chirurgia Università di Perugia – Sede di Terni- AA 2021/22- Lezioni Prof. Stefano Fiorucci
Programma lezioni patologia sistematica V- Prof. Stefano Fiorucci CLMMC -2021-22 TERNI Gastroenterologia PROGRAMMA LEZIONI V ANNO.doc
-